Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Minimally invasive treatment of myomas

04.03.2011
Syngo Embolization Guidance application from Siemens makes tumor therapy easier on the patient

Siemens Healthcare has added new functions to Syngo Embolization Guidance to simplify and accelerate the minimally invasive embolization of benign tumors such as myomas. The new version of the imaging software assists with treatment planning and delivery and makes it possible to check treatment outcomes. Syngo Embolization Guidance can speed up interventions as compared with previous embolization procedures, meaning that both contrast medium and dose can be reduced. This makes the occlusion of the blood vessels supplying the myoma easier on the patient than conventional methods.

The new version of Syngo Embolization Guidance from Siemens enables physicians to mark both the myoma and the blood vessels supplying the tumor on the pre-intervention CT (computed tomography) or MRT (magnetic resonance tomography) images. The software calculates the tumor volume and the access path to the myoma for the catheter automatically and shows both in the 3D planning image. Superimposing this image on the live fluoroscopic image during the intervention enables the radiologist to position the catheter easier than has previously been the case and largely removes the need for contrast medium, as the path is already marked and segmented in the 3D image. Treating myomas with Syngo Embolization Guidance is thus easier on the patient. Myomas (uterine leiomyomas) are benign thickenings of the myometrium. The Robert Koch Institute explains in its reporting to the German Federal Health Monitoring System in 2007 that myomas occur in significant numbers in around one third of women from the age of 35 onward in our part of the world1.

The traditional technique for myoma treatment involves the surgical removal of the tumors in an operation. A new minimally invasive method involving the occlusion of blood vessels has become established over recent years. Known as embolization, this technique sees a catheter inserted into the patient's vascular system through a very small access point, usually in the groin, and guided to the tumor. The catheter is navigated through the blood stream using a fluoroscopy system. The position of the catheter in the patient's body is displayed on screen in 2D images from an angiography unit, with contrast medium helping to make the area of interest stand out from the surrounding tissue. Key to this technique is the ability to bring the catheter into a position from which the blood vessels supplying the tumor can be occluded. Once the catheter is in place, emboli, for example very small particles of plastic, are injected directly into the blood vessels that supply the myoma until the blood supply to the benign tumor has been stopped. Deprived of essential nutrients and oxygen, the myomas shrink and eventually die.

The product mentioned herein is not commercially available. Due to regulatory reasons its future availability cannot be guaranteed.

The Siemens Healthcare Sector is one of the world’s largest healthcare solution providers and a leading manufacturer and service provider in the fields of medical imaging, laboratory diagnostics, hospital information technology and hearing instruments. It offers solutions covering the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. By optimizing clinical workflows oriented toward the most important clinical pictures, Siemens also strives to make healthcare faster, better and, at the same time, less expensive. Siemens Healthcare currently has some 48,000 employees worldwide and is present throughout the world. During fiscal 2010 (up to September 30) the Sector posted sales worth 12.4 billion euros and profits of around 750 million euros.

1 Robert Koch Institute, Ed.: Vol. 37 Gebärmuttererkrankungen [Hysteropathy], from the series "Gesundheitsberichterstattung des Bundes" [German Federal Health Monitoring], Berlin, January 2007

Marion Bludszuweit | Siemens Healthcare
Further information:
http://www.siemens.com/healthcare

More articles from Medical Engineering:

nachricht Novel PET tracer identifies most bacterial infections
06.10.2017 | Society of Nuclear Medicine and Molecular Imaging

nachricht Teleoperating robots with virtual reality
05.10.2017 | Massachusetts Institute of Technology, CSAIL

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>